Major Growth Driver Identified in 2025 Infusion Therapy Devices Market: Increasing Prevalence Of Chronic Diseases Is Driving The Growth Of The Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Infusion Therapy Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of infusion therapy devices has witnessed a quick expansion in the last few years. The market is projected to increase from $12.1 billion in 2024 to $13.33 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. The growth witnessed in the historic period owes itself to factors such as a rise in hospital admissions, enhancement in healthcare infrastructure, government programs, medical tourism, and reimbursement policies.

Infusion Therapy Devices Market Size Forecast: What's the Projected Valuation by 2029?
The market for infusion therapy devices is predicted to exponentially expand in the forthcoming years, reaching a significant size of $19.82 billion in 2029, with a compound annual growth rate (CAGR) of 10.4%. This projected growth can be ascribed to various factors such as the influence of personalized medicine, readiness for pandemics and responses, the use of wearable infusion devices, shift towards infusion therapy, and the growing digitalization in healthcare. Expectations for the future also include advancements like 5g connectivity, quantum computing, the integration of the internet of things (IoT), wearable health technology, as well as developments in voice assistants and natural language processing.

View the full report here:
https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

What Are the Drivers Transforming the Infusion Therapy Devices Market?
The surge in chronic illness is expected to fuel the infusion therapy devices market's growth. Chronic diseases are long-term health problems that need continuous medical care or affect daily life activities for one year or more. The rise in chronic diseases can result from poor lifestyle decisions, inactive behaviors, unhealthy dietary habits, and ecological factors, plus growing risk elements such as obesity, smoking, and stress. Infusion therapy devices combat chronic diseases by furnishing exact, regulated delivery of medications and fluids straight into the bloodstream, thereby ensuring steady and effective treatments for conditions like diabetes, autoimmune disorders, and cancer. This can improve patient results, increase convenience, and lessen the frequency of hospital visits. For instance, in January 2023, the National Center for Biotechnology Information (NCBI), a National Library of Medicine in the U.S., predicted that by 2050, the count of individuals aged 50 and over with at least one chronic disease will skyrocket by 99.5%, soaring from 71.522 million in 2020 to 142.66 million. Consequently, the surge in chronic diseases is fueling the infusion therapy devices market growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What Are the Key Trends Driving Infusion Therapy Devices Market Growth?
Key players in the infusion therapy device market are shifting their focus towards the creation of innovative strategies such as pressure-enabled drug delivery (PEDD) technology, improving the quality of treatment for liver and pancreatic tumors. PEDD technology pertains to a drug delivery system that utilizes pressure for augmenting the infusion of therapeutic drugs in tissues or organs, especially in situations where traditional methodologies might encounter difficulties. For instance, in November 2024, TriSalus Life Sciences, a medical technology firm based in the US, introduced the TriNav LV Infusion System and TriGuide Guiding Catheters into the market. These additions broadened their PEDD product suite with the motive of optimizing the delivery of treatment, enhancing treatment alternatives, and potentially boosting patient outcomes. The TriNav LV Infusion System encompasses unique traits such as wider blood vessels (3.5 to 5.0 mm), broadening the application of the TriSalus' Pressure-Enabled Drug Delivery (PEDD) technology to a wider patient base. This new introduction extends the PEDD device compatibility range from 1.5 mm to 5.0 mm vessels providing interventional radiologists with a wider variety of treatment alternatives. The TriGuide Guiding Catheters have a larger inner diameter, slick surface, and a back curve design that facilitates femoral access and promotes procedural efficiency. Early users have registered a 97% satisfaction rate, underscoring the system's efficiency and user-friendliness in oncology treatments.

Which Segments in the Infusion Therapy Devices Market Offer the Most Profit Potential?
The infusion therapy devices market covered in this report is segmented -

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors
2) By Mobility: Portable Infusion Pumps, Stationary Pumps
3) By Application: Oncology, Diabetes, Pain Management, Other Applications
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps
2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

Which Firms Dominate the Infusion Therapy Devices Market by Market Share and Revenue in 2025?
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

Which Regions Offer the Highest Growth Potential in the Infusion Therapy Devices Market?
North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.